NCT01385813

Brief Summary

This is an investigation of inflammatory markers in women destined to develop preeclampsia.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
129

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 1999

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 1999

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2004

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2004

Completed
7.2 years until next milestone

First Submitted

Initial submission to the registry

June 29, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 30, 2011

Completed
Last Updated

July 18, 2011

Status Verified

May 1, 2011

Enrollment Period

5.3 years

First QC Date

June 29, 2011

Last Update Submit

July 15, 2011

Conditions

Preeclampsia

Keywords

pre-eclampsiainflammatory markersserological biobankTo assess whether the inflammatory markers could be usefulin order to identify pregnant women at risk todevelop preeclampsia

Study Arms (1)

Pregnant women who develop preeclampsia

pregnant women who develop preeclampsia (n =43) compared to pregnant women fulfilling a normotensive pregnancy (n= 86).

Eligibility Criteria

Age20 Years - 43 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The study comprised 43 pregnant women who developed preeclampsia and 86 pregnant women who fulfilled a normotensive pregnancy. All women were of Caucasian origin, and were nulliparous.

You may qualify if:

  • Caucasian origin

You may not qualify if:

  • Previous diseases e.g. cardiovascular disease, diabetes, hypertension, inflammatory bowel disease, serious organ disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pre-Eclampsia

Condition Hierarchy (Ancestors)

Hypertension, Pregnancy-InducedPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 29, 2011

First Posted

June 30, 2011

Study Start

January 1, 1999

Primary Completion

May 1, 2004

Study Completion

May 1, 2004

Last Updated

July 18, 2011

Record last verified: 2011-05